Discover how Low Dose Naltrexone (LDN) is emerging as a promising adjunct therapy in integrative cancer care. This low-cost medication works through multiple mechanisms: blocking cancer cell receptors, enhancing immune function, and reducing inflammation. Research shows synergistic effects when combined with chemotherapy. Perfect for Breast Cancer Awareness Month, learn about LDN's potential role in supportive oncology and why compounding pharmacies are essential for precise,